This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2015 Nov;20(11):1285-7.

doi: 10.1016/j.drudis.2015.09.006. Epub 2015 Sep 10.

Cancer arises from stem cells: opportunities for anticancer drug discovery

Miguel López-Lázaro¹

Affiliations

PMID: 26365874
DOI: 10.1016/j.drudis.2015.09.006

Editorial

Cancer arises from stem cells: opportunities for anticancer drug discovery

Miguel López-Lázaro. Drug Discov Today. 2015 Nov.

. 2015 Nov;20(11):1285-7.

doi: 10.1016/j.drudis.2015.09.006. Epub 2015 Sep 10.

Author

Miguel López-Lázaro¹

Affiliation

¹ Department of Pharmacology, Faculty of Pharmacy, University of Seville, Spain. Electronic address: mlopezlazaro@us.es.

PMID: 26365874
DOI: 10.1016/j.drudis.2015.09.006

No abstract available

PubMed Disclaimer

Similar articles

Cancer stem cells as a target population for drug discovery.
Bouvard C, Barefield C, Zhu S. Bouvard C, et al. Future Med Chem. 2014 Sep;6(14):1567-85. doi: 10.4155/fmc.14.106. Future Med Chem. 2014. PMID: 25367391 Review.
Cancer stem cells as the relevant biomass for drug discovery.
Winquist RJ, Furey BF, Boucher DM. Winquist RJ, et al. Curr Opin Pharmacol. 2010 Aug;10(4):385-90. doi: 10.1016/j.coph.2010.06.008. Epub 2010 Jul 12. Curr Opin Pharmacol. 2010. PMID: 20630801 Review.
Cancer stem cell targeted therapy: progress amid controversies.
Wang T, Shigdar S, Gantier MP, Hou Y, Wang L, Li Y, Shamaileh HA, Yin W, Zhou SF, Zhao X, Duan W. Wang T, et al. Oncotarget. 2015 Dec 29;6(42):44191-206. doi: 10.18632/oncotarget.6176. Oncotarget. 2015. PMID: 26496035 Free PMC article. Review.
Tumour-initiating cells: challenges and opportunities for anticancer drug discovery.
Zhou BB, Zhang H, Damelin M, Geles KG, Grindley JC, Dirks PB. Zhou BB, et al. Nat Rev Drug Discov. 2009 Oct;8(10):806-23. doi: 10.1038/nrd2137. Nat Rev Drug Discov. 2009. PMID: 19794444 Review.
Cancer stem cell targeting: are we there yet?
Jung Y, Kim WY. Jung Y, et al. Arch Pharm Res. 2015 Mar;38(3):414-22. doi: 10.1007/s12272-015-0570-2. Epub 2015 Feb 10. Arch Pharm Res. 2015. PMID: 25666873 Review.

See all similar articles

Cited by

RNA-based therapies: A cog in the wheel of lung cancer defense.
Khan P, Siddiqui JA, Lakshmanan I, Ganti AK, Salgia R, Jain M, Batra SK, Nasser MW. Khan P, et al. Mol Cancer. 2021 Mar 19;20(1):54. doi: 10.1186/s12943-021-01338-2. Mol Cancer. 2021. PMID: 33740988 Free PMC article. Review.
Selective amino acid restriction therapy (SAART): a non-pharmacological strategy against all types of cancer cells.
López-Lázaro M. López-Lázaro M. Oncoscience. 2015 Nov 10;2(10):857-66. doi: 10.18632/oncoscience.258. eCollection 2015. Oncoscience. 2015. PMID: 26682277 Free PMC article.
RXRα provokes tumor suppression through p53/p21/p16 and PI3K-AKT signaling pathways during stem cell differentiation and in cancer cells.
Zhang R, Li H, Zhang S, Zhang Y, Wang N, Zhou H, He H, Hu G, Zhang TC, Ma W. Zhang R, et al. Cell Death Dis. 2018 May 1;9(5):532. doi: 10.1038/s41419-018-0610-1. Cell Death Dis. 2018. PMID: 29748541 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database